| Oral & Maxillofacial Surgery Associates Inc. | |
|
618 Central Center Chillicothe OH 45601 | |
| (740) 774-1175 | |
| (740) 774-1122 |
| Full Name | Oral & Maxillofacial Surgery Associates Inc. |
|---|---|
| Speciality | Dentist |
| Location | 618 Central Center, Chillicothe, Ohio |
| Authorized Official Name and Position | Larry J Schmit (PRESIDENT) |
| Authorized Official Contact | 7407741175 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Oral & Maxillofacial Surgery Associates Inc. Po Box 897 Chillicothe OH 45601 Ph: (740) 774-1175 | Oral & Maxillofacial Surgery Associates Inc. 618 Central Center Chillicothe OH 45601 Ph: (740) 774-1175 |
| NPI Number | 1548351497 |
|---|---|
| Provider Enumeration Date | 09/27/2006 |
| Last Update Date | 01/24/2018 |
| Medicare PECOS PAC ID | 6901830892 |
|---|---|
| Medicare Enrollment ID | O20080416000028 |
News Archive
Financial rewards for damages caused by mental injury at work have increased over the past five years by as much as 700%, according to a report released today by the Mental Health Commission of Canada (MHCC). The report warns that a perfect legal storm is brewing in the area of mental health protection at work, and points to emerging responsibilities for employers to provide a psychologically safe workplace. This is timely, since October is Canada's Healthy Workplace Month and next week is Mental Illness Awareness Week.
Emperra GmbH based in Germany is launching the world's first Bluetooth insulin pen on the market and therefore expanding its ESYSTA product system's function.
A new study has determined how often people should get screened for gastric or stomach cancer in high-risk regions of the world. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings could help reduce deaths from gastric cancer, which is the second most common cause of cancer-related mortality.
The study was published in the latest issue of the JAMA Network Open journal. For this the researchers followed up health, exercise and lifestyle data of 122,007 participants over 23 years to reach these conclusions.
Proteon Therapeutics, Inc., a privately held biopharmaceutical company developing novel, first-in-class pharmaceuticals to address the critical medical needs of patients with kidney and vascular diseases, today announced that its lead product, PRT-201, has received orphan drug designation in the European Union for the prevention of arteriovenous access dysfunction in hemodialysis patients.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548351497 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223S0112X | Dentist - Oral And Maxillofacial Surgery | 30019471 (Ohio) | Secondary |
| 1223S0112X | Dentist - Oral And Maxillofacial Surgery | 30010904 (Ohio) | Primary |
| Provider Name | Larry Schmitt |
|---|---|
| Provider Type | Practitioner - Oral Surgery |
| Provider Identifiers | NPI Number: 1386735231 PECOS PAC ID: 6305933128 Enrollment ID: I20080416000017 |
News Archive
Financial rewards for damages caused by mental injury at work have increased over the past five years by as much as 700%, according to a report released today by the Mental Health Commission of Canada (MHCC). The report warns that a perfect legal storm is brewing in the area of mental health protection at work, and points to emerging responsibilities for employers to provide a psychologically safe workplace. This is timely, since October is Canada's Healthy Workplace Month and next week is Mental Illness Awareness Week.
Emperra GmbH based in Germany is launching the world's first Bluetooth insulin pen on the market and therefore expanding its ESYSTA product system's function.
A new study has determined how often people should get screened for gastric or stomach cancer in high-risk regions of the world. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings could help reduce deaths from gastric cancer, which is the second most common cause of cancer-related mortality.
The study was published in the latest issue of the JAMA Network Open journal. For this the researchers followed up health, exercise and lifestyle data of 122,007 participants over 23 years to reach these conclusions.
Proteon Therapeutics, Inc., a privately held biopharmaceutical company developing novel, first-in-class pharmaceuticals to address the critical medical needs of patients with kidney and vascular diseases, today announced that its lead product, PRT-201, has received orphan drug designation in the European Union for the prevention of arteriovenous access dysfunction in hemodialysis patients.
› Verified 8 days ago
News Archive
Financial rewards for damages caused by mental injury at work have increased over the past five years by as much as 700%, according to a report released today by the Mental Health Commission of Canada (MHCC). The report warns that a perfect legal storm is brewing in the area of mental health protection at work, and points to emerging responsibilities for employers to provide a psychologically safe workplace. This is timely, since October is Canada's Healthy Workplace Month and next week is Mental Illness Awareness Week.
Emperra GmbH based in Germany is launching the world's first Bluetooth insulin pen on the market and therefore expanding its ESYSTA product system's function.
A new study has determined how often people should get screened for gastric or stomach cancer in high-risk regions of the world. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings could help reduce deaths from gastric cancer, which is the second most common cause of cancer-related mortality.
The study was published in the latest issue of the JAMA Network Open journal. For this the researchers followed up health, exercise and lifestyle data of 122,007 participants over 23 years to reach these conclusions.
Proteon Therapeutics, Inc., a privately held biopharmaceutical company developing novel, first-in-class pharmaceuticals to address the critical medical needs of patients with kidney and vascular diseases, today announced that its lead product, PRT-201, has received orphan drug designation in the European Union for the prevention of arteriovenous access dysfunction in hemodialysis patients.
› Verified 8 days ago
Kennedy Upperman Family Dentistry And Orthodontics Llc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 624 Central Ctr, Chillicothe, OH 45601 Phone: 740-773-4166 | |
Magnolia Dental Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 11 Medical Dr, Chillicothe, OH 45601 Phone: 740-775-8050 Fax: 740-775-8053 | |
John H. Patterson, Dds, Llc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 245 E 8th St, Chillicothe, OH 45601 Phone: 740-775-0095 | |
Wissler And Myers Family Dentistry, L.l.c. Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 245 E 8th St, Chillicothe, OH 45601 Phone: 740-775-0808 Fax: 740-775-0852 | |
Southern Ohio Oral & Facial Surgeons, Inc. Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 36 N Walnut St, Chillicothe, OH 45601 Phone: 740-773-6159 Fax: 740-773-1078 | |
Hopewell Health Centers Inc Dental Clinic Medicare: Medicare Enrolled Practice Location: 622 Central Ctr, Chillicothe, OH 45601 Phone: 740-851-5575 Fax: 740-851-4146 | |
Hopewell Health Centers, Inc. Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 622 Central Ctr, Chillicothe, OH 45601 Phone: 740-851-5575 Fax: 740-851-4146 |